The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 341:687-688 August 26, 1999 Number 9
NextNext

Early Revascularization in Cardiogenic Shock — A Positive View of a Negative Trial

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hochman, J. S.
-PubMed Citation
During the past two decades, revolutionary changes in our understanding of both the pathogenesis and the treatment of acute myocardial infarction have resulted in impressive gains in survival among patients hospitalized for this condition. The notable exception to the overall 25 to 35 percent relative reduction in early mortality that has occurred as a result of myocardial reperfusion1 is among patients in whom myocardial infarction is complicated by cardiogenic shock. Such patients make up 7 to 10 percent of the patients hospitalized for acute myocardial infarction. Characterized by hypotension and organ hypoperfusion, cardiogenic shock has an estimated mortality rate of . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.